Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

13 projects found matching your search criteria :

  1. Oxidation products of 5-methylcytosine as a new predictive markers for respons to systemic chemotherapy of breast cancer...

    Call: OPUS 9 , Panel: NZ5

    Principal investigator: dr hab. Marek Foksiński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  2. 5-Hydroxymethylcytosine (sixth DNA base) and its putative derivative - 5-hydroxymethyluracil as a new cancer biomarkers?...

    Call: OPUS 5 , Panel: NZ5

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  3. A search for a link between epigenetical changes - active DNA demethylation and oxidative stress based on cell culture s...

    Call: OPUS 4 , Panel: NZ1

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  4. Genome-wide high throughput analysis of 5-hydroxymethylcytosine (5hmC) in Danio rerio (zebra fish)

    Call: PRELUDIUM 3 , Panel: NZ2

    Principal investigator: Karolina Mierzejewska

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  5. Biomaterials inducing DNA demethylation as tools for future neuron regeneration therapies

    Call: OPUS 25 , Panel: ST8

    Principal investigator: dr hab. Katarzyna Nawrotek

    Politechnika Łódzka

  6. Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A sea...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  7. The impact of selective estrogen receptor modulators (SERMs) on active DNA demethylation in breast cancer cell lines

    Call: PRELUDIUM 15 , Panel: NZ3

    Principal investigator: Kinga Linowiecka

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  8. Investigation of involvement of particular TET protein family members in the generation of epigenetic DNA modyfications.

    Call: PRELUDIUM 15 , Panel: NZ1

    Principal investigator: Maciej Gawroński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  9. Adaptation of electrophoretic methods for the determination of the impact of food components on global DNA methylation.

    Call: PRELUDIUM 14 , Panel: NZ9

    Principal investigator: Monika Baranowska

    Politechnika Gdańska, Wydział Chemiczny

  10. A search for mechanism of anticancer properities of vitamin C; possible link between epigenetic DNA modyfications and vi...

    Call: OPUS 14 , Panel: NZ7

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  11. Hybrid implants controlling DNA demethylation intended for regeneration of peripheral nervous system

    Call: SONATA 13 , Panel: ST8

    Principal investigator: dr Katarzyna Nawrotek

    Politechnika Łódzka, Wydział Inżynierii Procesowej i Ochrony Środowiska

  12. 2-ketoglutarate and 2-hydroxyglutarate as a potential metabolic modulators of an active DNA demethylation process among ...

    Call: PRELUDIUM 13 , Panel: NZ5

    Principal investigator: dr Martyna Modrzejewska

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  13. Products of DNA demethylation and deamination pathways as new biomarkers of development and predictors of the outcome in...

    Call: OPUS 10 , Panel: NZ5

    Principal investigator: dr hab. Daniel Gackowski

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny